Industry: Consumer Goods
Published Date: 2026-04-19
Pages: 132 Pages
Report ld: 6518154
Request Sample
Customized Report
Nicotinamide Ribose Supplement Market Size(US$)

CAGR 2026-2032
6.8%
Market Size,2032
USD 677
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Nicotinamide Ribose Supplement market was valued at US$ 430 million in 2025 and is anticipated to reach US$ 677 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nicotinamide Ribose Supplement competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Nicotinamide Ribose Supplement is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Nicotinamide Ribose Supplement is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Nicotinamide Ribose Supplement include Jarrow, Codeage, Tru Niagen, The major vendors covered:, Chroma Dex, Elysium Health, Natural Nutra, Thorne, Zhejiang Jiahua Pharmchemical, Shenzhen Longgesheng Technology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Nicotinamide Ribose Supplement market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nicotinamide Ribose Supplement. The Nicotinamide Ribose Supplement market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Nicotinamide Ribose Supplement market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nicotinamide Ribose Supplement manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Nicotinamide Ribose Supplement manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Nicotinamide Ribose Supplement sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Nicotinamide Ribose Supplement Market Overview
1.1 Product Definition
1.2 Nicotinamide Ribose Supplement by Type
1.2.1 Global Nicotinamide Ribose Supplement Market Value by Type: 2025 vs 2032
1.2.2 Pharmaceutical Grade
1.2.3 Food Grade
1.2.4 Others
1.3 Nicotinamide Ribose Supplement by Application
1.3.1 Global Nicotinamide Ribose Supplement Market Value by Application: 2025 vs 2032
1.3.2 Food Industry
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Global Nicotinamide Ribose Supplement Market Size Estimates and Forecasts
1.4.1 Global Nicotinamide Ribose Supplement Revenue 2021–2032
1.4.2 Global Nicotinamide Ribose Supplement Sales 2021–2032
1.4.3 Global Nicotinamide Ribose Supplement Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Nicotinamide Ribose Supplement Market Competition by Manufacturers
2.1 Global Nicotinamide Ribose Supplement Sales Market Share by Manufacturers (2021–2026)
2.2 Global Nicotinamide Ribose Supplement Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Nicotinamide Ribose Supplement Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Nicotinamide Ribose Supplement, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Nicotinamide Ribose Supplement, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Nicotinamide Ribose Supplement, Product Types and Applications
2.7 Global Key Manufacturers of Nicotinamide Ribose Supplement, Date of Entry into the Industry
2.8 Global Nicotinamide Ribose Supplement Market Competitive Situation and Trends
2.8.1 Global Nicotinamide Ribose Supplement Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Nicotinamide Ribose Supplement Players Market Share by Revenue
2.8.3 Global Nicotinamide Ribose Supplement Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nicotinamide Ribose Supplement Market Scenario by Region
3.1 Global Nicotinamide Ribose Supplement Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Nicotinamide Ribose Supplement Sales by Region: 2021–2032
3.2.1 Global Nicotinamide Ribose Supplement Sales by Region: 2021–2026
3.2.2 Global Nicotinamide Ribose Supplement Sales by Region: 2027–2032
3.3 Global Nicotinamide Ribose Supplement Revenue by Region: 2021–2032
3.3.1 Global Nicotinamide Ribose Supplement Revenue by Region: 2021–2026
3.3.2 Global Nicotinamide Ribose Supplement Revenue by Region: 2027–2032
3.4 North America Nicotinamide Ribose Supplement Market Facts & Figures by Country
3.4.1 North America Nicotinamide Ribose Supplement Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Nicotinamide Ribose Supplement Sales by Country (2021–2032)
3.4.3 North America Nicotinamide Ribose Supplement Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nicotinamide Ribose Supplement Market Facts & Figures by Country
3.5.1 Europe Nicotinamide Ribose Supplement Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Nicotinamide Ribose Supplement Sales by Country (2021–2032)
3.5.3 Europe Nicotinamide Ribose Supplement Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicotinamide Ribose Supplement Market Facts & Figures by Region
3.6.1 Asia Pacific Nicotinamide Ribose Supplement Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Nicotinamide Ribose Supplement Sales by Region (2021–2032)
3.6.3 Asia Pacific Nicotinamide Ribose Supplement Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nicotinamide Ribose Supplement Market Facts & Figures by Country
3.7.1 Latin America Nicotinamide Ribose Supplement Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Nicotinamide Ribose Supplement Sales by Country (2021–2032)
3.7.3 Latin America Nicotinamide Ribose Supplement Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nicotinamide Ribose Supplement Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicotinamide Ribose Supplement Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Nicotinamide Ribose Supplement Sales by Country (2021–2032)
3.8.3 Middle East and Africa Nicotinamide Ribose Supplement Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicotinamide Ribose Supplement Sales by Type (2021–2032)
4.1.1 Global Nicotinamide Ribose Supplement Sales by Type (2021–2026)
4.1.2 Global Nicotinamide Ribose Supplement Sales by Type (2027–2032)
4.1.3 Global Nicotinamide Ribose Supplement Sales Market Share by Type (2021–2032)
4.2 Global Nicotinamide Ribose Supplement Revenue by Type (2021–2032)
4.2.1 Global Nicotinamide Ribose Supplement Revenue by Type (2021–2026)
4.2.2 Global Nicotinamide Ribose Supplement Revenue by Type (2027–2032)
4.2.3 Global Nicotinamide Ribose Supplement Revenue Market Share by Type (2021–2032)
4.3 Global Nicotinamide Ribose Supplement Price by Type (2021–2032)
5 Segment by Application
5.1 Global Nicotinamide Ribose Supplement Sales by Application (2021–2032)
5.1.1 Global Nicotinamide Ribose Supplement Sales by Application (2021–2026)
5.1.2 Global Nicotinamide Ribose Supplement Sales by Application (2027–2032)
5.1.3 Global Nicotinamide Ribose Supplement Sales Market Share by Application (2021–2032)
5.2 Global Nicotinamide Ribose Supplement Revenue by Application (2021–2032)
5.2.1 Global Nicotinamide Ribose Supplement Revenue by Application (2021–2026)
5.2.2 Global Nicotinamide Ribose Supplement Revenue by Application (2027–2032)
5.2.3 Global Nicotinamide Ribose Supplement Revenue Market Share by Application (2021–2032)
5.3 Global Nicotinamide Ribose Supplement Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Jarrow
6.1.1 Jarrow Company Information
6.1.2 Jarrow Description and Business Overview
6.1.3 Jarrow Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Jarrow Nicotinamide Ribose Supplement Product Portfolio
6.1.5 Jarrow Recent Developments/Updates
6.2 Codeage
6.2.1 Codeage Company Information
6.2.2 Codeage Description and Business Overview
6.2.3 Codeage Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Codeage Nicotinamide Ribose Supplement Product Portfolio
6.2.5 Codeage Recent Developments/Updates
6.3 Tru Niagen
6.3.1 Tru Niagen Company Information
6.3.2 Tru Niagen Description and Business Overview
6.3.3 Tru Niagen Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Tru Niagen Nicotinamide Ribose Supplement Product Portfolio
6.3.5 Tru Niagen Recent Developments/Updates
6.4 The major vendors covered:
6.4.1 The major vendors covered: Company Information
6.4.2 The major vendors covered: Description and Business Overview
6.4.3 The major vendors covered: Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 The major vendors covered: Nicotinamide Ribose Supplement Product Portfolio
6.4.5 The major vendors covered: Recent Developments/Updates
6.5 Chroma Dex
6.5.1 Chroma Dex Company Information
6.5.2 Chroma Dex Description and Business Overview
6.5.3 Chroma Dex Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Chroma Dex Nicotinamide Ribose Supplement Product Portfolio
6.5.5 Chroma Dex Recent Developments/Updates
6.6 Elysium Health
6.6.1 Elysium Health Company Information
6.6.2 Elysium Health Description and Business Overview
6.6.3 Elysium Health Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Elysium Health Nicotinamide Ribose Supplement Product Portfolio
6.6.5 Elysium Health Recent Developments/Updates
6.7 Natural Nutra
6.7.1 Natural Nutra Company Information
6.7.2 Natural Nutra Description and Business Overview
6.7.3 Natural Nutra Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Natural Nutra Nicotinamide Ribose Supplement Product Portfolio
6.7.5 Natural Nutra Recent Developments/Updates
6.8 Thorne
6.8.1 Thorne Company Information
6.8.2 Thorne Description and Business Overview
6.8.3 Thorne Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Thorne Nicotinamide Ribose Supplement Product Portfolio
6.8.5 Thorne Recent Developments/Updates
6.9 Zhejiang Jiahua Pharmchemical
6.9.1 Zhejiang Jiahua Pharmchemical Company Information
6.9.2 Zhejiang Jiahua Pharmchemical Description and Business Overview
6.9.3 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose Supplement Product Portfolio
6.9.5 Zhejiang Jiahua Pharmchemical Recent Developments/Updates
6.10 Shenzhen Longgesheng Technology
6.10.1 Shenzhen Longgesheng Technology Company Information
6.10.2 Shenzhen Longgesheng Technology Description and Business Overview
6.10.3 Shenzhen Longgesheng Technology Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Shenzhen Longgesheng Technology Nicotinamide Ribose Supplement Product Portfolio
6.10.5 Shenzhen Longgesheng Technology Recent Developments/Updates
6.11 Bontac Bio-engineering
6.11.1 Bontac Bio-engineering Company Information
6.11.2 Bontac Bio-engineering Description and Business Overview
6.11.3 Bontac Bio-engineering Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Bontac Bio-engineering Nicotinamide Ribose Supplement Product Portfolio
6.11.5 Bontac Bio-engineering Recent Developments/Updates
6.12 Springtide
6.12.1 Springtide Company Information
6.12.2 Springtide Description and Business Overview
6.12.3 Springtide Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Springtide Nicotinamide Ribose Supplement Product Portfolio
6.12.5 Springtide Recent Developments/Updates
6.13 Solaray
6.13.1 Solaray Company Information
6.13.2 Solaray Description and Business Overview
6.13.3 Solaray Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Solaray Nicotinamide Ribose Supplement Product Portfolio
6.13.5 Solaray Recent Developments/Updates
6.14 Life Extension
6.14.1 Life Extension Company Information
6.14.2 Life Extension Description and Business Overview
6.14.3 Life Extension Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Life Extension Nicotinamide Ribose Supplement Product Portfolio
6.14.5 Life Extension Recent Developments/Updates
6.15 ChromaDex Corporation
6.15.1 ChromaDex Corporation Company Information
6.15.2 ChromaDex Corporation Description and Business Overview
6.15.3 ChromaDex Corporation Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 ChromaDex Corporation Nicotinamide Ribose Supplement Product Portfolio
6.15.5 ChromaDex Corporation Recent Developments/Updates
6.16 Thorne Research
6.16.1 Thorne Research Company Information
6.16.2 Thorne Research Description and Business Overview
6.16.3 Thorne Research Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Thorne Research Nicotinamide Ribose Supplement Product Portfolio
6.16.5 Thorne Research Recent Developments/Updates
6.17 Tesseract Medical Research
6.17.1 Tesseract Medical Research Company Information
6.17.2 Tesseract Medical Research Description and Business Overview
6.17.3 Tesseract Medical Research Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Tesseract Medical Research Nicotinamide Ribose Supplement Product Portfolio
6.17.5 Tesseract Medical Research Recent Developments/Updates
6.18 Biotrend Chemikalien
6.18.1 Biotrend Chemikalien Company Information
6.18.2 Biotrend Chemikalien Description and Business Overview
6.18.3 Biotrend Chemikalien Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Biotrend Chemikalien Nicotinamide Ribose Supplement Product Portfolio
6.18.5 Biotrend Chemikalien Recent Developments/Updates
6.19 Vitacost.com
6.19.1 Vitacost.com Company Information
6.19.2 Vitacost.com Description and Business Overview
6.19.3 Vitacost.com Nicotinamide Ribose Supplement Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Vitacost.com Nicotinamide Ribose Supplement Product Portfolio
6.19.5 Vitacost.com Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicotinamide Ribose Supplement Industry Chain Analysis
7.2 Nicotinamide Ribose Supplement Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicotinamide Ribose Supplement Production Mode & Process Analysis
7.4 Nicotinamide Ribose Supplement Sales and Marketing
7.4.1 Nicotinamide Ribose Supplement Sales Channels
7.4.2 Nicotinamide Ribose Supplement Distributors
7.5 Nicotinamide Ribose Supplement Customer Analysis
8 Nicotinamide Ribose Supplement Market Dynamics
8.1 Nicotinamide Ribose Supplement Industry Trends
8.2 Nicotinamide Ribose Supplement Market Drivers
8.3 Nicotinamide Ribose Supplement Market Challenges
8.4 Nicotinamide Ribose Supplement Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 430 million in 2025 and is projected to reach US$ 677 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 153
USD 3950.00
(Single User License)
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 405 million in 2024 to US$ 638 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-17
Pages: 179
USD 4900.00
(Single User License)
The global Nicotinamide Ribose Supplement market size was US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-11-17
Pages: 102
USD 4250.00
(Single User License)
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-01-31
Pages: 136
USD 3950.00
(Single User License)
The global market for Nicotinamide Ribose Supplement was valued at US$ 405 million in the year 2024 and is projected to reach a revised size of US$ 638 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-01-31
Pages: 102
USD 2900.00
(Single User License)
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 382 million in 2024 to US$ 566.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published Date: 2024-04-09
Pages: 114
USD 4900.00
(Single User License)
The global Nicotinamide Ribose Supplement market was valued at US$ 361 million in 2023 and is anticipated to reach US$ 566.9 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 106
USD 2900.00
(Single User License)
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 430 million in 2025 and is projected to reach US$ 677 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 153
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 405 million in 2024 to US$ 638 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-17
Pages: 179
The global Nicotinamide Ribose Supplement market size was US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-11-17
Pages: 102
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-01-31
Pages: 136
The global market for Nicotinamide Ribose Supplement was valued at US$ 405 million in the year 2024 and is projected to reach a revised size of US$ 638 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-01-31
Pages: 102
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 382 million in 2024 to US$ 566.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published: 2024-04-09
Pages: 114
The global Nicotinamide Ribose Supplement market was valued at US$ 361 million in 2023 and is anticipated to reach US$ 566.9 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 106
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now